Telehealth Cognitive Behavioral Therapy for youth at risk for psychosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility and effectiveness of telehealth interventions for individuals aged 14-25 who are at clinical high risk for psychosis. It focuses on delivering Group and Family-Based Cognitive Behavioral Therapy (CBT) and individual CBT through telehealth to improve accessibility and engagement in treatment. Participants will be randomly assigned to one of the adapted CBT interventions, and the study will measure recruitment rates, attendance, and retention, as well as the impact on cognitive biases and social connectedness. The goal is to reduce barriers to accessing care and improve clinical outcomes for youth at risk.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Age 14-25
* Ability to participate in assessments and treatment in English
* Meets criteria for psychosis-risk on SIPS
* Stable on medications; no changes within 1 month prior to enrollment
* Identification of one "family member" with \>4 hours/week contact who is willing to participate ("Family member" can be any blood relative, spouse, significant other, or close friend whom the subject identifies as a consistent and important person in their life).

Exclusion criteria:

* Intellectual disability (IQ\<70)
* Medical condition known to cause psychosis
* Moderate or severe substance use disorder and active use within the past 30 days.

Where it's running

• Icahn School of Medicine at Mount Sinai
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Yulia Landa — Icahn School of Medicine at Mount Sinai
• Study coordinator: Yulia Landa, PsyD, MS
• Email: yulia.landa@mssm.edu
• Phone: 212-585-4658

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Accelerated Brain Stimulation for Young People at Risk of Psychosis

  This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.

  Recruiting Douglas Mental Health University Institute · Verdun, Quebec · NCT07786714

• Recovery-oriented suicide prevention for young people at clinical high risk for psychosis

  This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.

  Recruiting at 2 sites University of California, San Diego · Los Angeles, California and 1 other locations · NCT07756567

• Mindfulness group experiences for young people at high risk for or early in psychosis

  This project tries to understand how group mindfulness sessions feel for French-speaking young people aged 15–30 who are at ultra‑high risk for psychosis or have had a first episode.

  Recruiting at 2 sites Centre Psychothérapique de Nancy · Laxou and 1 other locations · NCT07499934

• Biomarker changes after MT1988 dosing in young people at high risk for psychosis

  This will test whether two doses of MT1988 taken twice daily for 8 weeks change biomarker tests in 17–30-year-olds at high risk for psychosis compared with placebo.

  Recruiting at 15 sites Phase 1/2 Monument Therapeutics Limited · Irvine, California and 14 other locations · NCT07226895

• Digital DBT for Youth at Risk of Psychosis

  This study tests a self-guided digital DBT program to help young people aged 14–35 who are at clinical high risk for psychosis, comparing it to usual care over eight weeks.

  Recruiting Centre for Addiction and Mental Health · Toronto, Ontario · NCT06928935

• French version of the Schizophrenia Proneness Instrument for children and adolescents (SPI-CY)

  This project will test the French SPI-CY to see if it reliably identifies French-speaking adolescents (ages 12–17) who are at high risk for developing psychosis.

  Recruiting at 2 sites Centre Psychothérapique de Nancy · Lille and 2 other locations · NCT06649552

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.